In HCC patients, MDSCs are increased in the blood and within the tumor, inducing programmed death-ligand 1 (PD-L1) expression in advanced stages through interaction with KCs [76] to suppress the adaptive immune response. The gene discussed is TBCE; the disease is neoplasm.